Anker SD, Butler J, Filippatos G, Khan MS, et al. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial. Circulation 2020 Nov 11. doi: 10.1161/CIRCULATIONAHA.120.051824.
PMID: 33175585